In the CENTERA study, significant functional and anatomic improvements were achieved by treating macular edema (ME) secondary to central retinal vein occlusion (CRVO) with a treat-and-extend (T&E) dosing regimen. Varun Chaudhary, leading author of the study, explains why T&E might be an ideal approach in these patients.